Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease
Detailed price information for Alpha Cognition Inc (ACOG-Q) from The Globe and Mail including charting and trades.